News

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.
A Ludwig Cancer Research study has identified a complex chain of molecular chatter by which cancer cells, exploiting ordinary ...
The National Cancer Center Research Institute in Tokyo reports that a newly isolated gut bacterium, designated ...
Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like ...
The COVID virus can cause brain inflammation, which, in some cases, becomes more serious and increase the risk of Alzheimer's ...
When a pathogen is detected, the CNLs and RNLs respond by forming multiprotein complexes known as resistosomes, which act as ...
Cats with a severe coronavirus disease experienced an immune system boost after treatment with an MSC therapy, opening translational avenues for humans.
The FDA has loosened safety restrictions for six CAR T-cell immunotherapies, used in treating a number of blood cancers.
Recently, a research team from Chongqing Medical University, led by Prof. Wei Huang, Dr. Wei Bao, and Dr. Yiting Lei, has successfully developed a novel engineered extracellular matrix (eECM) to ...
A study published in Experimental Gerontology has found that low doses of THC may help improve wound healing in older ...
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...